Effects of Antenatal Corticosteroids Given Prior to 26 Weeks' Gestation: A Systematic Review of Randomized Controlled Trials

ABSTRACT

Although it is generally accepted that antenatal corticosteroids reduce neonatal complications after preterm labor, it is unclear at what gestational age this effect starts to occur. We conducted a systematic review of the literature to determine the effects of antenatal corticosteroids given to women at risk of preterm birth <26 weeks' gestation. Two reviewers independently searched electronic databases and the Cochrane Library for randomized controlled trials including women at imminent birth at a gestational age <26 weeks. Nine randomized trials were included. Meta-analyses and meta-regression of trials including participants with a lower gestational age revealed no significant reduction of neonatal mortality and morbidity in the corticosteroid group as compared with nonintervention, in contrast to clear evidence of beneficial effects in trials including women given corticosteroids at a later gestational age. A gestational age-dependent effect of antenatal corticosteroids on neonatal outcomes with lesser treatment benefits in patients <26 weeks' gestational age appears to exist. There is no evidence from randomized controlled trials to support or refute the recommendation of administrating antenatal corticosteroids to women at risk of preterm birth <26 weeks' gestation.

Corticosteroids - antenatal - preterm - respiratory distress syndrome

REFERENCES

• 1 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.  Cochrane Database Syst Rev. 2006;  3 CD004454
• 2 Newnham J P, Jobe A H. Should we be prescribing repeated courses of antenatal corticosteroids?.  Semin Fetal Neonatal Med. 2009;  14 157-163
• 3 Miracle X, Di Renzo G C, Stark A, Fanaroff A, Carbonell-Estrany X, Saling E. Coordinators Of World Association of Perinatal Medicine Prematurity Working Group . Guideline for the use of antenatal corticosteroids for fetal maturation.  J Perinat Med. 2008;  36 191-196
• 4 Lamont R F. International Preterm Labour Council . Evidence-based labour ward guidelines for the diagnosis, management and treatment of spontaneous preterm labour.  J Obstet Gynaecol. 2003;  23 469-478
• 5 Crane J, Armson A, Brunner M Executive Committee of the Society of Obstetricians and Gynaecologists of Canada et al. Antenatal corticosteroid therapy for fetal maturation.  J Obstet Gynaecol Can. 2003;  25 45-52
• 6 Royal College of Obstetricians and Gynaecologists .Antenatal Corticosteroids to Prevent Respiratory Distress Syndrome. 2004. Available at: http://www.rcog.org.uk/files/rcog-corp/GT7AntenatalCorticosterodsamenaea.pef Accessed July 15, 2010
• 7 Di Renzo G C, Roura L C. European Association of Perinatal Medicine-Study Group on Preterm Birth . Guidelines for the management of spontaneous preterm labor.  J Perinat Med. 2006;  34 359-366
• 8 Sweet D, Bevilacqua G, Carnielli V Working Group on Prematurity of the World Association of Perinatal Medicine et al. European consensus guidelines on the management of neonatal respiratory distress syndrome.  J Perinat Med. 2007;  35 175-186
• 9 Pignotti M S, Scarselli G, Barberi I et al.. Perinatal care at an extremely low gestational age (22-25 weeks). An Italian approach: the “Carta di Firenze”.  Arch Dis Child Fetal Neonatal Ed. 2007;  92 F515-F516
• 10 Committee on Obstetric Practice. American College of Obstetricians and Gynecologists . ACOG committee opinion. Antenatal corticosteroid therapy for fetal maturation. Number 402: Antenatal corticosteroid therapy for fetal maturation.  Obstet Gynecol. 2008;  11 805-807
• 11 Moher D, Liberati A, Tetzlaff J, Altman D G. PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.  PLoS Med. 2009;  6 e1000097
• 12 Higgins JPT, Green S Cochrane Handbook for Systematic Review of Interventions Version 5.0.2 [Updated September 2009] The Cochrane Library 2009 http://Available at: www.cochrane-handbook.org Accessed December 3, 2009
• 13 Amorim M M, Santos L C, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia.  Am J Obstet Gynecol. 1999;  180 1283-1288
• 14 Cararach V, Sentis J, Botet F, De Los Rios L. A multicenter, prospective randomized study in premature rupture of membranes (PROM). Respiratory and infection complications in the newborn. Proceedings of the 12th European Congress of Perinatal Medicine, Lyon, France 1990: 216
• 15 Pattinson R C, Makin J D, Funk M Dexiprom Study Group et al. The use of dexamethasone in women with preterm premature rupture of membranes—a multicentre, double-blind, placebo-controlled, randomised trial.  S Afr Med J. 1999;  89 865-870
• 16 Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].  Tunis Med. 2002;  80 260-265
• 17 Nelson L H, Meis P J, Hatjis C G, Ernest J M, Dillard R, Schey H M. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management.  Obstet Gynecol. 1985;  66 55-58
• 18 Qublan H S, Malkawi H Y, Hiasat M S et al.. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes.  Clin Exp Obstet Gynecol. 2001;  28 183-186
• 19 Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.  Pediatrics. 1972;  50 515-525
• 20 Taeusch Jr H W, Frigoletto F, Kitzmiller J et al.. Risk of respiratory distress syndrome after prenatal dexamethasone treatment.  Pediatrics. 1979;  63 64-72
• 21 Teramo K, Hallman M, Raivio K O. Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant.  Pediatr Res. 1980;  14 (4 Pt 1) 326-329
• 22 Schutte M F, Treffers P E, Koppe J G, Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour.  Br J Obstet Gynaecol. 1980;  87 127-131
• 23 Morales W J, Angel J L, O'Brien W F, Knuppel R A. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study.  Obstet Gynecol. 1989;  73 (5 Pt 1) 721-726
• 24 Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome.  Am J Obstet Gynecol. 1981;  141 276-287
• 25 Block M F, Kling O R, Crosby W M. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.  Obstet Gynecol. 1977;  50 186-190
• 26 Carlan S J, Parsons M, O'Brien W F, Krammer J. Pharmacologic pulmonary maturation in preterm premature rupture of membranes.  Am J Obstet Gynecol. 1991 [abstract];  164 371
• 27 Gamsu H R, Mullinger B M, Donnai P, Dash C H. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial.  Br J Obstet Gynaecol. 1989;  96 401-410
• 28 Kari M A, Hallman M, Eronen M et al.. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.  Pediatrics. 1994;  93 730-736
• 29 Lewis D F, Brody K, Edwards M S, Brouillette R M, Burlison S, London S N. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics.  Obstet Gynecol. 1996;  88 801-805
• 30 Doran T A, Swyer P, MacMurray B et al.. Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome.  Am J Obstet Gynecol. 1980;  136 313-320
• 31 Garite T J, Rumney P J, Briggs G G et al.. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation.  Am J Obstet Gynecol. 1992;  166 646-651
• 32 Silver R K, Vyskocil C, Solomon S L, Ragin A, Neerhof M G, Farrell E E. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation.  Obstet Gynecol. 1996;  87 (5 Pt 1) 683-691
• 33 Parsons M T, Sobel D, Cummiskey K, Constantine L, Roitman J. Steroid, antibiotic and tocolytic vs. no steroid, antibiotic and tocolytic management in patients with preterm PROM at 25–32 weeks. Proceedings of the 8th Annual Meeting of the Society of Perinatal Obstetricians, Las Vegas, NV 1988: 44
• 34 Salokorpi T, Sajaniemi N, Hällback H, Kari A, Rita H, von Wendt L. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years.  Acta Paediatr. 1997;  86 294-298
• 35 Liu J, Wang Q, Zhao J H, Chen Y H, Qin G L. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.  J Trop Pediatr. 2006;  52 355-359
• 36 Elimian A, Garry D, Figueroa R, Spitzer A, Wiencek V, Quirk J G. Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial.  Obstet Gynecol. 2007;  110 26-30
• 37 Crowther C A, Harding J E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.  Cochrane Database Syst Rev. 2007;  (3) CD003935
• 38 Maher J E, Cliver S P, Goldenberg R L, Davis R O, Copper R L. March of Dimes Multicenter Study Group . The effect of corticosteroid therapy in the very premature infant.  Am J Obstet Gynecol. 1994;  170 869-873
• 39 Figueras-Aloy J, Serrano M M, Rodríguez J P SEN1500 Spanish Neonatal Network et al. Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23- to 28-week gestational age preterm infants.  Am J Perinatol. 2005;  22 441-448
• 40 Costeloe K, Hennessy E, Gibson A T, Marlow N, Wilkinson A R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.  Pediatrics. 2000;  106 659-671
• 41 Willet K E, Jobe A H, Ikegami M, Newnham J, Brennan S, Sly P D. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs.  Pediatr Res. 2000;  48 782-788
• 42 Ballard P L, Ning Y, Polk D, Ikegami M, Jobe A H. Glucocorticoid regulation of surfactant components in immature lambs.  Am J Physiol. 1997;  273 (5 Pt 1) L1048-L1057
• 43 Pesonen A K, Räikkönen K, Lano A, Peltoniemi O, Hallman M, Kari M A. Antenatal betamethasone and fetal growth in prematurely born children: implications for temperament traits at the age of 2 years.  Pediatrics. 2009;  123 e31-e37
• 44 Mazumder P, Dutta S, Kaur J, Narang A. Single versus multiple courses of antenatal betamethasone and neonatal outcome: a randomized controlled trial.  Indian Pediatr. 2008;  45 661-667
• 45 Carroll M A, Vidaeff A C, Mele L National Institute of Child Health and Human Development (NICHD) Maternal Fetal Medicine Units Network (MFMU) et al. Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids.  Obstet Gynecol. 2008;  111 1352-1358
• 46 Koivisto M, Peltoniemi O M, Saarela T, Tammela O, Jouppila P, Hallman M. Blood glucose level in preterm infants after antenatal exposure to glucocorticoid.  Acta Paediatr. 2007;  96 664-668
• 47 Peltoniemi O M, Kari M A, Tammela O Repeat Antenatal Betamethasone Study Group et al. Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth.  Pediatrics. 2007;  119 290-298
• 48 Wapner R J, Sorokin Y, Thom E A National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy.  Am J Obstet Gynecol. 2006;  195 633-642
• 49 Crowther C A, Haslam R R, Hiller J E, Doyle L W, Robinson J S. Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group . Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.  Lancet. 2006;  367 1913-1919
• 50 Kashanian M, Dadkhah F, Mokhtari F. Effect of intramuscular administration of dexamethasone on the duration of labor.  Int J Gynaecol Obstet. 2008;  102 259-262
• 51 Goetzl L, Zighelboim I, Badell M et al.. Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial.  Am J Obstet Gynecol. 2006;  195 1031-1037
• 52 Ozer A, Kanat-Pektas M, Ozer S, Tapisiz O L, Zulfikaroglu E E, Danisman N. The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome.  Arch Gynecol Obstet. 2009;  280 65-70
• 53 Fonseca J E, Méndez F, Cataño C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial.  Am J Obstet Gynecol. 2005;  193 1591-1598